Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rxo (RXO) Change in Cash (2021 - 2025)

Rxo (RXO) has disclosed Change in Cash for 5 consecutive years, with -$8.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Change in Cash rose 60.0% year-over-year to -$8.0 million, compared with a TTM value of -$17.0 million through Dec 2025, down 156.67%, and an annual FY2025 reading of -$17.0 million, down 156.67% over the prior year.
  • Change in Cash was -$8.0 million for Q4 2025 at Rxo, down from $7.0 million in the prior quarter.
  • Across five years, Change in Cash topped out at $166.0 million in Q2 2022 and bottomed at -$99.0 million in Q4 2023.
  • Average Change in Cash over 5 years is -$812500.0, with a median of $0.0 recorded in 2021.
  • The sharpest move saw Change in Cash tumbled 4350.0% in 2022, then soared 340.0% in 2024.
  • Year by year, Change in Cash stood at -$2.0 million in 2021, then crashed by 4350.0% to -$89.0 million in 2022, then decreased by 11.24% to -$99.0 million in 2023, then skyrocketed by 79.8% to -$20.0 million in 2024, then surged by 60.0% to -$8.0 million in 2025.
  • Business Quant data shows Change in Cash for RXO at -$8.0 million in Q4 2025, $7.0 million in Q3 2025, and $3.0 million in Q2 2025.